Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 4/21/2016 |
| Start Date: | February 2012 |
| End Date: | October 2016 |
| Contact: | Michael Rosenberg, MD |
| Email: | mrosenberg@jfkhealth.org |
| Phone: | 732-321-7010 |
This is a nonblinded Case-only study that evaluates the effects of Agmatine Sulfate on small
fiber peripheral neuropathy. Patients will be started on Agmatine sulfate (a metabolite of
Arginine) and monitored for two months. Improvement will be noted on their response to the
Neuropathic Pain Questionnaire. Additionally the investigators will note improvement by
performing autonomic function testing at the beginning and end of the study.
fiber peripheral neuropathy. Patients will be started on Agmatine sulfate (a metabolite of
Arginine) and monitored for two months. Improvement will be noted on their response to the
Neuropathic Pain Questionnaire. Additionally the investigators will note improvement by
performing autonomic function testing at the beginning and end of the study.
Inclusion Criteria:
- Men and Women Ages 18-75 with symptoms of small Fiber Neuropathy and have been
diagnosed via autonomic function testing and or skin biopsy
Exclusion Criteria:
- Women who are pregnant or breast feeding, patients with history of substance abuse,
and patients with myelopathy
We found this trial at
1
site
Click here to add this to my saved trials
